Increased Expression of TIGIT/CD57 in Peripheral Blood/Bone Marrow NK Cells in Patients with Chronic Myeloid Leukemia

The antitumor activity of NK cells in patients with chronic myeloid leukemia (CML) is inhibited by the leukemia microenvironment. Recent studies have identified that the expression of TIGIT, CD57, and KLRG1 is related to the function, maturation, and antitumor capabilities of NK cells. However, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Danlin, Xu, Ling, Liu, Lian, Zeng, Xiangbo, Zhong, Juan, Lai, Jing, Zheng, Runhui, Jin, Zhenyi, Chen, Shaohua, Zha, Xianfeng, Huang, Xin, Lu, Yuhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7578715/
https://www.ncbi.nlm.nih.gov/pubmed/33102599
http://dx.doi.org/10.1155/2020/9531549

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7578715/
https://www.ncbi.nlm.nih.gov/pubmed/33102599
http://dx.doi.org/10.1155/2020/9531549

Ejemplares similares